Eaton Vance Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.65M Sell
67,889
-68
-0.1% -$3.11K ﹤0.01% 967
2022
Q2
$2.62M Sell
67,957
-304
-0.4% -$11.6K ﹤0.01% 995
2022
Q1
$3.31M Buy
68,261
+47
+0.1% +$2.42K ﹤0.01% 1012
2021
Q4
$5.01M Sell
68,214
-42
-0.1% -$3.45K 0.01% 787
2021
Q3
$6.18M Buy
68,256
+68,173
+82,136% +$5.8M 0.01% 672
2021
Q2
$5K Sell
83
-191
-70% -$7.06K ﹤0.01% 2645
2021
Q1
$7K Buy
+274
New +$6.59K ﹤0.01% 2480

Other funds holding ASTH

Eaton Vance Management's ASTH Position: Q3 2022 in Review

Eaton Vance Management reduced its Astrana Health (ASTH) stake by 0.1% in Q3 2022, selling an estimated $3.11K and leaving 67,889 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Eaton Vance Management first reported a position in ASTH in Q1 2021 and has held it in 7 quarters since. The position peaked at $6.18M in Q3 2021. 154 funds tracked by Wall St. Rank hold ASTH as of Q3 2022.

  • Eaton Vance Management held 67,889 shares of Astrana Health worth $2.65M as of Q3 2022.
  • Eaton Vance Management sold 68 Astrana Health shares in Q3 2022, an estimated $3.11K.
  • Astrana Health made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #967 holding.
  • Eaton Vance Management first reported a position in Astrana Health in Q1 2021 and has held it in 7 quarters since.
  • Eaton Vance Management's Astrana Health position peaked at $6.18M in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Astrana Health as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.